Skip to main content
. 2008 May 22;155(3):308–313. doi: 10.1016/j.vetpar.2008.05.012

Table 1.

Oocyst shedding and presence of diarrhoea* in control (treatment and excipient) and treated groups of lambs experimentally infected with C. parvum “cattle” genotype

Lamb age (days) Treatment control
Excipient control
Prophylactic/therapeutic treatment 1 (Bobel-24 at 50 mg/kg of body weight)
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6
5 1d 1d 2d 2d 1d 1d 2d 3d 1d 2d 1d 1d 0 0 0 0 0 0
6 4d 2d 4d 2d 2d 3d 3d 3d 2d 4d 3d 2d 0 0 0 0 0 1
7 4d 4d 4d 4d 3d 4d 3d 3d 3d 3d 4d 2d 0 0 1d 0 0 1
8 4d 4d 3d 3d 3d 3d 3d 2d 3d 2d 3d 4d 0 0 1d 1 1 2d
9 3d 4d 2d 3d 2d 3d 2d 2d 2d 1d 3d 4d 0 0 2d 1 0 1
10 3d 3d 2d 2d 1 2d 1 2d 1d 1d 3d 3d 0 1 1 2 0 1
11 2d 3d 2d 2 1 2 1 2d 1 1 3d 3d 0 1 1 2 0 0
12 1d 2d 1 1 1 1 1 1 1 1 2d 2d 0 1 1 3 0 0
13 1d 2 1 1 1 1 0 1 1 1 2d 2d 0 1 1 2 0 0
14 1d 1 1 1 1 1 0 0 0 2 2d 2d 0 1 0 1 0 0
15 1 1 0 0 0 0 0 0 0 2 1 1 0 0 0 0 0 0
16 1 1 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0
17 1 1 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0
18 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Lamb age (days) Prophylactic/theraeutic treatment 2 (Bobel-24 at 500 mg/kg of body weight)
Therapeutic treatment (Bobel-24 at 500 mg/kg of body weight)
1 2 3 4 5 6 1 2 3 4 5 6
5 0 0 2d 0 2d 2d 1 1 1 1 0 1
6 2d 0 3d 4d 3d 2d 1 1 1 1 2 1
7 2d 2 2d 3d 2 2 1 1 1 1 2 2
8 1 1 2 3 2 3d 2d 2d 2 2 2 2
9 1 1 1 2 1 3d 2d 2d 2 2 1 2
10 1 0 1 2 1 2 3d 2 1 1 1 2
11 0 0 1 1 0 1 3d 2 1 1 2 2
12 0 0 0 1 0 1 2d 1 1 0 2 3
13 0 0 0 0 0 0 2d 0 1 0 4 4
14 0 0 0 0 0 0 1 0 1 1 3 2
15 0 0 0 0 0 0 1 0 0 1 2 2
16 0 0 0 0 0 0 0 0 0 0 1 1
17 0 0 0 0 0 0 0 0 0 0 0 0
18 0 0 0 0 0 0a 0 0 0 0 0 0

d, Diarrhoea; 0 (no oocyst), 1 (≤1 oocyst), 2 (2–5 oocysts), 3 (6–10 oocysts), 4 (>10 oocysts).

a

Died.